Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer.
Spyridon P BasourakosJohn W DavisBrian F ChapinJohn F WardCurtis A PettawayLouis L PistersNeema NavaiMary F AchimXuemei WangHsiang-Chun ChenSeungtaek ChoiDeborah KubanPatricia TroncosoSam HanashTimothy C ThompsonJeri KimPublished in: BJU international (2017)
Baseline plasma Cav-1 level was an independent predictor of disease classification. New methods for refining AS and intervention may result.